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Abstract
Purpose Symptoms of Multiple Sclerosis (MS) differentially impact upon quality of life (QoL) and a comprehensive measure 
is required for use in observational and interventional studies. This study examines the abbreviated World Health Organi-
sation Quality of Life tool (WHOQOL-BREF) which was designed to be used as a broad measure of QoL across different 
cultures and diseases.
Methods Data were collected from 3186 subjects as part of the TONiC study in MS and was examined with a systematic, 
iterative approach using Rasch analysis to investigate the internal construct validity of the WHOQOL-BREF.
Results Mean age was 49.8 years (SD 11.8), disease duration was 11.2 years (SD 9.6) and 73.2% were female. Subjects rep-
resented all stages of MS with EDSS scores of 0–4, 4.5–6.5, 7–7.5 and ≥ 8 seen in 49.8%, 38.5%, 6.8% and 4.9% of patients, 
respectively. Using a super-item approach, it was possible to demonstrate fit to the assumptions of the Rasch model for 3 of 
the 4 domains of the WHOQOL-BREF (physical, psychological and environment) as well as a broad 24-item total score. In 
addition, item subsets derived from the stem of each question were shown to function as novel scales measuring impact and 
life satisfaction. We have provided transformation tables from ordinal raw scores to interval scales where data are complete.
Conclusions The validation of multiple conceptual frameworks validates the WHOQOL-BREF as a powerful and flexible 
end-point for use in clinical trials and in testing conceptual models of factors influencing QoL in MS.
Keywords Multiple sclerosis · Rasch analysis · Clinical outcomes · Quality of life
Introduction
Multiple Sclerosis (MS), is a neurodegenerative disorder that 
affects all aspects of life [1–3]. Fluctuating symptoms and 
a variable decline in functioning, can differentially impact 
upon perceived quality of life [4] ⁠. As all aspects of life can 
be affected, a conceptual model that draws on the biomedical 
and social sciences paradigm and which incorporates, bio-
logical, psychological and social aspects of health is needed 
to represent that variable experience [5] ⁠. One model was 
postulated by Wilson and Cleary in 1995 which incorpo-
rates aspects of health status (e.g. symptoms and function-
ing) and separately, QoL, as well as potential environmental 
moderators and psychological mediators [6] ⁠. The model is 
consistent with recently identified priority outcomes for tri-
als of disease modifying therapies in MS, that is symptoms, 
disability (functioning) and QoL [7] ⁠.
Given this, one task in order to operationalize the model is 
to select the Patient Reported Outcome Measures (PROM’s), 
or other assessments that should be used to specify the 
model. There is no clear consensus on a scale to measure 
QoL in MS, for example five recent phase 3 treatment tri-
als since 2012 have employed a variety of scales includ-
ing the Short Form Survey (SF-36), EQ5D, MSQOL-54, 
and Functional Assessment of Multiple Sclerosis (FAMS) 
[8–12] ⁠. The SF-36 and EQ5D are fundamentally measures 
of health status with functioning as a predominant construct 
[13] ⁠, whereas, the Wilson and Cleary model differentiates 
between functioning and QoL. The MSQOL-54 is a deriv-
ative of the SF36 expanded to include items relevant for 
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people with MS and as such is thought to be a end-point 
measure, as is the FAMS which combines physical and 
social functioning as well as well-being.
The current study uses data from a large population of 
MS patients recruited into the TONiC study https ://tonic 
.thewa ltonc entre .nhs.uk/ to evaluate the abbreviated World 
Health Organisation Quality of Life tool (WHOQOL-BREF) 
as a potential QoL outcome for such a conceptual model. 
This 26-item scale was developed across 18 countries to be 
used as a broad measure of QoL across different cultures and 
diseases [14]. Structural equational modelling of the original 
scale showed that the items could be drawn together into 4 
domains; physical health, psychological, social relationships 
and environment. As well as evaluating the conventional 
domain-based scoring of the WHOQOL-BREF, this paper 
suggests a different way of summating the item set to pro-
vide just two distinct domains for consideration, as well as 
an overall score.
Methods
Recruitment
Patients were recruited as part of the Trajectories of Out-
comes in Neurological Conditions (TONiC) study investi-
gating predictors of quality of life in chronic neurological 
disease. Subjects with MS were recruited from 23 centres 
across the UK and were asked to complete a questionnaire 
pack which included the WHOQOL-BREF amongst a vari-
ety of PROM’s designed to map on to the International Clas-
sification of Functioning, Disability and Health (ICF) Brief 
Core Set for MS [15]. The project aimed to recruit subjects 
across a broad range of ages, diseases subtypes and disabili-
ties. Patients who were physically unable to complete the 
questionnaires were permitted to use a scribe to report their 
answers on the form. All participants received written infor-
mation and informed consent was obtained from all indi-
vidual participants included in the study prior to enrolment.
Rasch analysis
The Rasch model provides a systematic and objective 
method to evaluate a set of criteria consistent with fun-
damental measurement, that is the type of measurement 
normally found in the physical sciences [16]⁠. These crite-
ria include the stochastic (probabilistic) ordering of items, 
monotonicity (increase in item responses consistent with 
underlying trait), local item independence (zero correlation 
between items when conditioned on the score), unidimen-
sionality and group invariance (no difference in response 
to item by group membership when at the same level of 
(in this case) QoL [17]. Thus data from a scale are tested 
against the requirements of the Rasch model in a process 
widely known as Rasch analysis. Full details of this process 
are given elsewhere [18].
⁠Recent methodological developments have updated the 
previously published guidelines. Thus, local item independ-
ence was examined by constructing a residual item correla-
tion matrix between all items. The residual of an item is the 
difference between the estimate of item difficulty given the 
model, and the observed item difficulty, standardised to a 
mean of zero and standard deviation of 1. Residual correla-
tions of + 0.2 above the average correlation are considered an 
indicator of a breach of the local independence criteria [19]⁠. 
That is, there is something else, other than the trait being 
measured (e.g. QoL) that is causing an association between 
the items. This may be due to the fact that the items are close 
replications of one another, or multidimensionality is pre-
sent. When local item dependency is observed, it is accom-
modated through a strategy of grouping items, either along 
the lines of a priori known domains where the grouping is 
consistent with a testlet, or from other evidence where the 
grouping is post hoc, contingent on the analysis, and referred 
to as ‘super items’ [20, 21]. This latter approach can include 
two super items, created by allocating alternative items to 
each super item, on the basis that as the scale (domain) was 
supposed to be summated into a single score, then alter-
native items should demonstrate a near perfect latent cor-
relation between the two, while absorbing most, if not all, 
local dependency within the item set. Analysis using two 
super items has the advantage of providing a more robust 
conditional chi-square test of fit, together with the propor-
tion of variance retained in a bi-factor equivalent solution, 
consistent with the explained common variance (EVC) in the 
bi-factor literature [22–24]⁠. A bi-factor solution is where the 
latent estimate is based upon the first (Rasch) factor, upon 
which all items load but also load onto secondary factors 
EVC should be > 0.9 if the scale is to be considered essen-
tially unidimensional, that is greater than 90% of the vari-
ance is common and retained in the latent estimate.
The data were further evaluated for differential item 
functioning (DIF) by age group, gender, MS subtype and 
duration [25] ⁠. Analysis of DIF examines whether each item 
performs equally across different subgroups, given the same 
level of the underlying trait. So, contextual characteristics 
who have the same level of quality of life. Evidence of DIF 
was sought from graphical displays of group-specific item 
characteristic curves, and statistically if the p-value derived 
from an ANOVA analysis was significant at the 5% level 
with a Bonferroni correction applied. Where a testlet or 
super-item solution is obtained, and DIF is shown to be still 
present, the substantive nature of this DIF is tested by com-
paring unadjusted and adjusted person estimates. Should the 
t test of this comparison (for paired or repeated measures) be 
significant, then an effect size of the difference is calculated 
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which should be less than 0.1, in which case DIF is deemed 
to be small and no action is taken [26]. All analyses were 
performed using RUMM2030 software [27].
Targeting of each scale was assessed by person-threshold 
(transition between categories) distribution plots, which 
plot the range of QoL recorded by subjects against the 
range measured by each scale. Spearman’s Rho correlation 
coefficients were calculated to ascertain concurrent valid-
ity between the derived scales and the established scales 
included in the TONiC study: the EQ5D and Leeds MS 
QoL (LMSQoL) [28, 29]. Finally, the precision of the vari-
ous domains of the WHOQOL-BREF was examined with 
respect to the standard error of measurement (SEM) and the 
smallest detectable difference (SDD) [30, 31] ⁠.
Thus, the properties of the WHOQOL-BREF were first 
examined according to the original structure of physical, 
psychological, environment and social health subscales, then 
two new domains were considered reflecting the stems of the 
items, that is ‘impact’ and ‘satisfaction’ and finally, the data 
were examined for a 24-item total solution. Where a solution 
was identified to fit the assumptions of the Rasch model, a 
conversion table was calculated to enable transformation of 
the original ordinal scores to an interval scale without the 
use of specialist software.
Results
Subjects
3186 people with MS were recruited into the study by mid-
2017 and had returned the baseline questionnaire. Mean age 
was 49.8 years (SD 11.8) and mean duration of MS (since 
diagnosis) was 11.2 years (SD9.6). Almost three quarters 
(73.2%) were female. Three fifths (60.3%) had a Relapsing 
Remitting form of MS (RRMS), 11.7% Primary Progressive; 
22.9% Secondary Progressive, and 5.1% a rapidly evolving 
form of RRMS. Almost half (49.8%) had an EDSS of 0–4.0; 
38.5% were at level 4.5–6.5; 6.75% at level 7–7.5 and 4.9% 
had an EDSS ≥ 8.0.
Rasch analysis
Data from the WHOQOL-BREF were fit to the Rasch model 
in a series of analyses representing different grouping of 
items shown in Table 1, ideal values for fit statistics derived 
from Rasch analysis literature are provided within the table 
[19, 32]. The requirement for local independence of items 
was found to be breached for all groups. For example, in the 
24-item-based scale, the items ‘How much do you enjoy 
life’ and ‘To what extent do you feel your life to be mean-
ingful’, had a residual correlation of 0.481. For the physical 
subscale, whose average residual correlation was − 0.16, the 
items ‘How well are you able to get around’ and ‘How satis-
fied are you with your ability to perform your daily activi-
ties’ had a residual correlation of 0.198. As a consequence, 
in practice all the item groups (domains) were resolved into 
two super items.
Physical health
The 7-item physical subscale (Table 1, Analysis 1) showed 
significant misfit to the model, including a breach of the 
local independence solution, multidimensionality, and sub-
stantial DIF by age, duration and disease subtype.
All thresholds were ordered, supporting the monotonic-
ity requirement. The two ‘super-item’ approach resolved 
the fit, with the two latent estimates perfectly correlated, 
and the explained common variance at 1.0, indicating that 
no unique variance had been discarded to achieve a unidi-
mensional latent estimate which was confirmed by the t test 
(Analysis 2). However, DIF remained. Graphically it was 
hard to determine where the DIF was present, but the MS 
subtype showed some slight deviation for rapidly evolving 
(RE) RRMS (Fig. 1). Substantive DIF was thus tested by 
contrasting the estimates from a split solution (RE + the rest) 
against an unsplit solution, anchored by the split super-item 
parameters. The effect size of such a contrast was 0.032. As 
such no further action was taken for DIF on the physical 
subscale.
Psychological health
The 6-item psychological scale also showed misfit to the 
model, with local dependencies, multidimensionality and 
significant DIF (Analysis 3). All item thresholds were 
ordered. The two super items showed good fit to the model 
(Analysis 4). While duration was invariant, DIF was pre-
sent for age, gender and MS subtype. Graphical interpreta-
tion was not helpful, but it appeared that females showed 
the most deviation from the expected curve, and so a super 
item was split by gender. The effect size for the difference 
between estimates was 0.031, no further action was taken for 
DIF and the original unsplit estimate used.
Social relationships
The three-item social relationships scale (Analysis 5) failed 
to show fit to the Rasch model. With just three items, the test 
for unidimensionality was underpowered. The reliability of 
the scale remained below that considered a minimum for 
group use. As such, no resolution was attempted.
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Environment
The original 8 item environment scale (Analysis 6) showed 
misfit to the model, multidimensionality and DIF by age and 
disease subtype. The two super items demonstrated adequate 
fit within a bi-factor equivalent solution, having shed some 
4% of the variance to achieve a unidimensional latent esti-
mate (Analysis 7). DIF was absent for all items.
Impact and satisfaction scales
It is also possible to view the 24-item set from a different 
perspective, based upon the format of the stem of each ques-
tion. In this way two separate scales assessing impact (items 
3–15 and 26) and satisfaction (items 16–25) may be consid-
ered. The 14-item impact scale (Analysis 8) did not fit the 
Rasch model. While all thresholds were ordered, the scale 
was multidimensional, DIF manifested for all contextual 
factors, and local item dependencies were present. A two 
super-item approach resolved the issue (Analysis 9). While 
DIF was present for age and disease subtype, no variation 
was observed from the graphical interpretation.
A similar result as found for the 10-item satisfaction 
scale. Initially the data did not fit the model and showed 
evidence of multidimensionality, local item dependencies, 
two disordered thresholds and DIF on all contextual fac-
tors. (Analysis 10). Combining items into two super items 
resulted in satisfactory fit and unidimensionality, having 
discarded none of the variance (Analysis 11). DIF was still 
in evidence for age and disease subtype, although it was 
almost impossible to visualize any difference in the group-
specific item characteristic curves (e.g. see Fig. 2) and, given 
earlier findings and their magnitude of effect size observed, 
no further action was taken. The targeting of the satisfaction 
domain was good, showing a slightly higher level of satisfac-
tion than the average of the scale, which itself showed a near 
perfect distribution across the trait (Fig. 3).
Fig. 1  Physical health—dif-
ferential item functioning by 
disease subtype. DIF plot show-
ing slight deviation for rapidly 
evolving (RE) RRMS in the 
physical health domain
Fig. 2  Differential item 
functioning (DIF) by disease 
subtype on one super item in 
the life satisfaction domain. DIF 
plot displaying marginal DIF 
for one super item in the life 
satisfaction domain
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24  item total scale
The 24-item scale showed considerable misfit, multidimen-
sionality, local dependencies, and DIF across all contextual 
factors, often for several items (Analysis 12). Two strategies 
were considered to see if a total score was valid: a testlet 
strategy based upon the four domains, and a strategy based 
upon alternative items allocated to two super items.
Creating 4 testlets according the 4 original subscales 
failed to resolve fit to the model (Analysis 13). The psycho-
logical and social testlets were dependent, DIF was present 
for all contextual factors, and 8% of the variance had to be 
discarded in order to achieve a unidimensional latent esti-
mate (although adequate under a bi-factor solution).
In contrast, the two super-item analysis displayed near 
perfect fit, with excellent reliability, and none of the variance 
was discarded to obtain the unidimensional latent estimate 
(Analysis 14). DIF remained on all but the duration factor, 
but here the sample size was influencing small group differ-
ences that were not substantive. For example, splitting the 
youngest age off in one super item, and comparing unsplit 
with (Anchored) split age gave an effect size for the differ-
ence in person estimates of 0.05.
Transformations of the ordinal raw score of the above 
scales to interval scale latent metrics are available in Table 2.
Scale precision
The SEM and SDD of each domain are shown in Table 3. 
The original domains (excluding social which has 
insufficient reliability), require a difference between two 
groups/times of the order of 16–18% of their operational 
ranges to overcome the error, whereas, in descending order, 
the satisfaction, impact and total (24-item) domains require 
between 14 and 8% of their operational ranges to be above 
error.
Discrimination across disease subtype
While all one-way ANOVA’s showed a significance level 
of < 0.001 for discrimination of each domain across subtype, 
the non-discriminating pairwise results from the post hoc 
Bonferroni provide some insight (Table 4). Generally, the 
significant difference was driven by the contrast between 
Relapsing Remitting, and other subtypes. None of the 
domains showed a post hoc significant difference between 
Primary and Secondary Progressive subtypes. The only post 
hoc significance on the psychological domain was between 
Primary Progressive and Relapsing Remitting, yet the effect 
size of this difference was just 0.23. For the physical domain, 
the effect size for the difference between Primary Progres-
sive and Relapsing Remitting was 0.54.
Scale correlations
Correlations between the derived scales and existing sub-
scales included in the TONiC study are shown in Table 5, 
all correlations were found to be significant with a p-value 
of < 0.001.
Fig. 3  Person-item distribution of the life satisfaction domain. Person-item distribution plot showing well matched distributions of levels of life 
satisfaction between the scale items and the study population
1967Quality of Life Research (2020) 29:1961–1972 
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Table 2  Raw score to interval-
scale transformation of domains
Raw score 24 Item Physical Psychological Environment Impact Life satisfaction
0 0.0 0.0 0.0 0.0 0.0 0.0
1 4.7 2.3 1.6 2.5 3.4 2.6
2 7.8 3.9 2.8 4.2 5.8 4.3
3 9.7 5.0 3.7 5.3 7.6 5.5
4 11.2 5.8 4.5 6.2 9.1 6.4
5 12.5 6.5 5.2 6.9 10.4 7.2
6 13.5 7.2 6.0 7.5 11.5 7.9
7 14.5 7.8 6.7 8.1 12.5 8.6
8 15.4 8.4 7.4 8.7 13.5 9.2
9 16.2 8.9 8.2 9.3 14.4 9.8
10 17.0 9.5 9.0 9.9 15.3 10.4
11 17.8 10.0 9.8 10.5 16.1 11.0
12 18.6 10.5 10.6 11.1 16.9 11.5
13 19.3 11.1 11.4 11.7 17.6 12.1
14 20.0 11.6 12.3 12.4 18.4 12.7
15 20.8 12.2 13.2 13.1 19.1 13.2
16 21.5 12.8 14.1 13.8 19.8 13.8
17 22.2 13.4 15.1 14.5 20.4 14.4
18 22.8 14.1 16.1 15.2 21.1 15.0
19 23.5 14.8 17.2 16.0 21.7 15.5
20 24.2 15.6 18.2 16.8 22.3 16.2
21 24.8 16.4 19.4 17.6 22.9 16.8
22 25.5 17.4 20.6 18.4 23.5 17.4
23 26.1 18.4 22.1 19.3 24.1 18.1
24 26.8 19.6 24.0 20.2 24.7 18.8
25 27.4 20.9 21.1 25.2 19.6
26 28.0 22.6 22.1 25.8 20.4
27 28.6 24.9 23.1 26.4 21.2
28 29.2 28.0 24.2 27.0 22.1
29 29.8 25.4 27.5 23.0
30 30.4 26.9 28.1 23.9
31 31.0 29.0 28.7 25.0
32 31.6 32.0 29.3 26.0
33 32.2 29.9 27.2
34 32.8 30.5 28.4
35 33.4 31.2 29.6
36 33.9 31.8 31.0
37 34.5 32.5 32.5
38 35.1 33.2 34.3
39 35.7 34.0 36.7
40 36.3 34.7 40.0
41 36.9 35.5
42 37.5 36.3
43 38.0 37.2
44 38.6 38.1
45 39.2 39.0
46 39.8 40.0
47 40.5 41.0
48 41.1 42.1
49 41.7 43.2
50 42.3 44.4
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Table 2  (continued) Raw score 24 Item Physical Psychological Environment Impact Life satisfaction
51 42.9 45.6
52 43.6 47.0
53 44.2 48.4
54 44.9 50.2
55 45.6 52.7
56 46.2 56.0
57 46.9
58 47.6
59 48.3
60 49.1
61 49.8
62 50.5
63 51.3
64 52.1
65 52.9
66 53.7
67 54.5
68 55.3
69 56.2
70 57.1
71 57.9
72 58.9
73 59.8
74 60.7
75 61.7
76 62.7
77 63.7
78 64.7
79 65.8
80 66.9
81 68.0
82 69.1
83 70.2
84 71.4
85 72.6
86 73.9
87 75.1
88 76.4
89 77.8
90 79.2
91 80.7
92 82.4
93 84.4
94 87.0
95 90.6
96 96.0
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Discussion
The study population included a wide range of ages and dis-
ease subtypes but with a higher proportion of patients with 
early and relapsing forms of MS compared with the general 
population. Since the study aimed to validate the perfor-
mance of the WHOQOL-BREF as a measure of QOL rather 
than describing the absolute levels of QOL, the question of 
whether the subject characteristics are proportional to the 
overall MS population is not crucial. The study population 
covered the full spectrum of MS, with a large sample size 
and a lack of significant DIF seen in the scale performance. 
This demonstrates that the WHOQOL-BREF can be used 
in cross sectional studies to compare QOL across a broad 
range of MS subtypes and can be utilised in longitudinal 
study designs to track meaningful changes over a prolonged 
period of time.
It was not possible to achieve a satisfactory Rasch-based 
solution for the item-based analysis of the WHOQOL-
BREF. Each domain showed misfit to the Rasch model 
requirements, multidimensionality (not the social domain) 
and significant DIF. As an existing scale, the super-item 
approach reflects how the scale is used in everyday practice, 
as a domain score. Allocating alternative items to the two 
super items imposes no a priori decisions about a domain’s 
structure, and there is no reason to suppose that these should 
reflect anything other than two identical aspects of the total 
score. The current analysis supports this in that most analy-
ses showed a latent correlation of 1 between the two super-
item estimates. Furthermore, the investigation of ‘substan-
tive’ DIF has shown that, in the current study, the DIF was 
driven by the sample size and that, in practice, its impact on 
person estimates was negligible.
Given this, raw scores as a sufficient statistic for the phys-
ical, psychological and environmental scales were achieved, 
together with two different perspectives on the item set, 
namely impact and satisfaction scales, as well as a 24-item 
Table 3  Precision of the WHOQOL-BREF domains and other 
PROMS
%SDC is that difference as % of operational range of the scale
SD standard deviation, SEM standard error of measurement, SDC 
smallest detectable change
Domain Mean SD SEM SDC %SDC
WHOQoL-Bref
 Physical 13.19 4.45 1.78 4.93 17.62
 Psychological 13.11 4.08 1.41 3.92 16.32
 Environmental 18.95 4.79 1.97 5.47 17.11
 Life satisfaction 20.64 5.70 1.97 5.47 13.68
 Impact 31.82 7.00 1.85 5.13 9.17
 Total 50.59 12.26 2.74 7.60 7.92
Other PROMS
 EQ-5D-5L 0.6776 0.2492 0.1176 0.3262 32.62
 MSQoL 11.566 3.601 1.6104 4.4638 18.60
Table 4  Discrimination across disease subtype
Mean and standard deviation (SD) on Rasch transformed measures
Domain Primary progressive
A
Rapidly evolving
B
Relapsing remitting
C
Secondary 
progressive
D
All
cases
Scale range Bonferroni 
not
significant
Physical 11.9 (3.7) 13.1 (4.7) 14.2 (4.7) 11.2 (3.0) 13.2 (4.4) 0–28 A&D
Psychological 12.6 (3.8) 13.1 (4.2) 13.5 (4.1) 12.3 (3.8) 13.1 (4.1) 0–24 A&B; A&D; B&C; 
B&D
Environmental 17.9 (4.1) 18.3 (4.6) 19.7 (5.0) 17.6 (4.0) 19.0 (4.8) 0–32 A&B; A&D; B&D
Impact 30.3 (6.0) 31.1 (7.0) 33.1 (7.3) 29.4 (5.5) 31.8 (7.0) 0–56 A&D
Life satisfaction 19.0 (4.7) 20.7(5.5) 21.7 (6.1) 18.6 (4.4) 20.6 (5.8) 0–40 A&D; B&C
Total (24 item) 47.3 (10.3) 49.9 (11.9) 53.0 (12.9) 46.1 (9.3) 50.6 (12.2) 0–96 A&B; A&D
Table 5  Spearman’s Rho 
correlation coefficients between 
QoL measures in TONiC Study
QoL VAS EQ5D Leeds QoL WHOQOl-
BREF Total
WHO-
QOl-
BREF
Impact
EQ5D 0.561
Leeds QoL 0.520 0.537
WHOQOl-Bref total 0.634 0.710 0.739
WHOQOl-Bref impact 0.622 0.698 0.691 0.957
WHOQOl-Bref life satisfaction 0.579 0.635 0.714 0.928 0.789
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total score. Transformation from ordinal raw scores to inter-
val scaled latent estimates were thus available but can only 
be used when data are complete. The social scale should be 
excluded as its reliability was too low for any useful appli-
cation, although its three items are included in the impact/
satisfaction/24-item solutions.
The precision of the original domains, as expressed by 
the SEM, were similar to those recently found in an obser-
vational study in oncology [33]⁠. What the current study sug-
gests is that considering the alternative ‘impact’ and ‘life 
satisfaction’ domains, as well as the total score based upon 
all 24 items, may be more efficient, in that the percentage 
of the operational range of the scale to be covered to be 
clear of error, is smaller for those domains than the original 
domains. Future work to determine the minimal clinically 
important difference will further refine the clinical utility 
and interpretation of these scores.
The study included patients of varying age, sex, gender 
and disability representative of a broad range of patients 
with MS. The lack of substantive DIF suggests that the 
WHOQOL-BREF can be used as a generic measure of 
QoL in the MS population. Previous attempts to investigate 
whether the WHOQOL-BREF can be used as a single unidi-
mensional construct have differed significantly in the modifi-
cations required to the scale in order to fit the Rasch model. 
Wang et al. required the deletion of 8 items to achieve fit to 
the scale due to substantial levels of DIF, thereby detracting 
from the reliability and original internal construct validity of 
the scale [34] ⁠. Noerholm et al. found evidence of significant 
multidimensionality when applying the Danish version of 
the scale to the general population [35] ⁠. More recently, a 
study used testlets to overcome the problems of local item 
dependency in order to demonstrate fit to the Rasch model in 
a UK population of patients with post polio syndrome [36] ⁠. 
The success of the same approach (post hoc super items) 
in the current study provides empirical evidence to support 
the use of the WHOQOL-BREF as it was intended, as a 
universal measure of QoL that can be utilised across differ-
ent diseases.
Application of Rasch analysis demonstrated the validity 
of these domains with a solution that did not require any 
alterations to the administration of the scale. The internal 
construct validity of each new scale can be assessed by 
examining the domains from which each item is derived. 
The impact scale contains 4 items from the physical 
domain and 5 each from psychological and environment. 
The satisfaction scale contains one item from psychologi-
cal domain and 3 each from physical, social and environ-
ment. Therefore, each can be broadly thought of as an 
even mix of the different aspects of QoL assessed by the 
WHOQOL-BREF.
Whilst the WHOQOL-BREF has previously been applied 
in varied MS populations in observational and interventional 
studies and to validate novel measures [37–39] ⁠, to our 
knowledge this is the first study to apply modern methods 
to investigate the psychometric properties of the scale in a 
population with MS. In addition, the study has provided a 
novel concept for using the scale. The stem of the questions 
in the WHOQOL-BREF suggests 2 sets of items assessing 
impact and satisfaction with QoL. Indeed, Hathorne and 
colleagues explicitly stated that the WHOQoL-BREF could 
be regarded as a ‘life satisfaction’ scale, given 10 of the 
24 summated items focused upon satisfaction [40] (REF). 
Perhaps most importantly, the perspective of the scale and 
its individual items are those of appraisal rather than under-
taking of a given task. For example, ‘How satisfied are you 
with the support you get from your friends?’; ‘How satisfied 
are you with yourself?’’; ‘How satisfied are you with your 
sleep?’ ‘How safe do you feel in your daily life?’ As such the 
WHOQoL-BREF provides a different perspective of QOL to 
most of those used previously for MS and can offer a useful 
end-point for conceptual models such as that proposed by 
Wilson and Cleary [6].
All correlations between measures were significant but 
correlations were lower between the WHOQOL-BREF 
and the EQ5D, which was designed as a measure of health 
status. Life satisfaction is an essential component of sub-
jective well-being, thereby distinguishing the concept 
from health status and functioning [41]. The correlation 
between the new satisfaction scale and the disease-specific 
LMSQol included in the TONiC study found a common 
variance of 50%, which can be accounted for by both the 
appraisal perspective and the fact that the satisfaction 
scale addresses wider issues such as the environment and 
access to health care. In an RCT, the LMSQoL may be 
more appropriate as the impact of the specific disease is 
key and other social and environmental factors should be 
randomized out. In observational studies and where the 
full biopsychosocial model is applied (such as the Wilson 
and Cleary model), then the life satisfaction scale may be 
more suitable. However, the LMSQoL is less efficient than 
the WHOQOL-BREF as analysis of the SDD indicates it 
requires a change in 18.6% of the scale width to overcome 
random error compared with 14 and 9% of the satisfac-
tion and impact domains, respectively, and 8% for the total 
score. The total score of the WHOQOL-BREF may be suit-
able for comparison across different diseases and popula-
tions due to its comprehensive coverage of aspects of QoL 
and the broad context of its development and validation. It 
offers a unique appraisal perspective of the lived experi-
ence of those with MS. Together with the interval scaled 
latent estimates derived from the Rasch model, it provides 
a powerful tool for use with structural equational model-
ling and similar methods to investigate the factors which 
influence perceived QoL in MS.
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